Book Your Appointment
Verified Patient Reviews of DCDC Diagnostic Center in Dubai
Verified reviews and real patient stories from Dubai Healthcare City
I'm very satisfied with this medical clinic. I had my first pregnancy screening here. It was affordable and very professional. The radiologist was welcoming, kind, and made the experience great.
Aizhan Tokmanbetova
Hurt my knee Friday night and got an MRI appointment Sunday evening (booked Sunday afternoon). Waited about 2 minutes and was done in just over 30 minutes. The team was amazing, friendly and efficient.
Kirsten Evans
Dr. Osama's team was gentle and amazing. After a bad experience elsewhere, my pelvic exam here was much more professional. Great report and very precise.
Mary
CA-125 Blood Test in Dubai: Ovarian Cancer Marker Screening and Monitoring
Accurate CA-125 testing for ovarian cancer risk assessment, pelvic symptom evaluation, and treatment response monitoring
Precise Measurement
Advanced immunoassay for accurate CA-125 quantification
Clinical Context
Results interpreted by gynaecologists within your full health profile
Fast Results
Most CA-125 results available within 24-48 hours
Specialist Pathway
Direct referral to gynaecology for abnormal findings and further evaluation
CA-125, or Cancer Antigen 125, is a protein biomarker that is elevated in the blood of many women with ovarian cancer. Ovarian cancer is often called the silent killer because it typically presents with vague, non-specific symptoms that are easily attributed to other conditions, and by the time it is diagnosed, the disease has frequently advanced to later stages where treatment outcomes are less favourable. The CA-125 blood test, when used appropriately in the right clinical context, serves as a valuable tool for risk assessment, diagnostic support, treatment monitoring, and recurrence detection. Understanding both its strengths and limitations is essential for informed healthcare decisions.
At DCDC, we offer CA-125 testing as both a standalone marker and as part of comprehensive panels for women's health evaluation. The test measures the concentration of CA-125 protein in the blood, with levels below 35 units per millilitre generally considered normal. However, CA-125 is not exclusively produced by ovarian cancer cells. It is also found on the surface of normal cells in the fallopian tubes, endometrium, peritoneum, pleura, and pericardium, which means that various benign conditions can also cause elevations. This dual nature makes clinical interpretation essential and is why CA-125 should always be evaluated by a qualified physician within the full clinical context.
Precise Measurement
Advanced immunoassay for accurate CA-125 quantification
Clinical Context
Results interpreted by gynaecologists within your full health profile
Fast Results
Most CA-125 results available within 24-48 hours
Specialist Pathway
Direct referral to gynaecology for abnormal findings and further evaluation
CA-125 Blood Test in Dubai: Ovarian Cancer Marker Screening and Monitoring
Accurate CA-125 testing for ovarian cancer risk assessment, pelvic symptom evaluation, and treatment response monitoring
CA-125, or Cancer Antigen 125, is a protein biomarker that is elevated in the blood of many women with ovarian cancer. Ovarian cancer is often called the silent killer because it typically presents with vague, non-specific symptoms that are easily attributed to other conditions, and by the time it is diagnosed, the disease has frequently advanced to later stages where treatment outcomes are less favourable. The CA-125 blood test, when used appropriately in the right clinical context, serves as a valuable tool for risk assessment, diagnostic support, treatment monitoring, and recurrence detection. Understanding both its strengths and limitations is essential for informed healthcare decisions.
At DCDC, we offer CA-125 testing as both a standalone marker and as part of comprehensive panels for women's health evaluation. The test measures the concentration of CA-125 protein in the blood, with levels below 35 units per millilitre generally considered normal. However, CA-125 is not exclusively produced by ovarian cancer cells. It is also found on the surface of normal cells in the fallopian tubes, endometrium, peritoneum, pleura, and pericardium, which means that various benign conditions can also cause elevations. This dual nature makes clinical interpretation essential and is why CA-125 should always be evaluated by a qualified physician within the full clinical context.
Dr. Hadi Komshi
Our CA-125 Test Services
Comprehensive ca-125 test services at DCDC Dubai Healthcare City.
CA-125 Screening
Ovarian cancer marker blood test for risk assessment and symptom evaluation.
CA-125 Monitoring
Serial testing for treatment response tracking and recurrence surveillance.
Pelvic Mass Evaluation
CA-125 combined with ultrasound findings for ovarian mass risk stratification.
Women's Cancer Screening Panel
CA-125 alongside other relevant markers for comprehensive women's cancer assessment.
All services performed by DHA-licensed specialists
Who Should Get CA-125 Test?
CA-125 testing is recommended for women with symptoms suggestive of ovarian pathology, those with significant family history of ovarian or breast cancer, and patients requiring treatment monitoring for diagnosed ovarian cancer or endometriosis.
Persistent bloating lasting more than two weeks without clear cause
Pelvic or abdominal pain that is new, persistent, or unexplained
Difficulty eating or feeling full quickly with unexplained weight changes
Urinary urgency or frequency without urinary tract infection
Family history of ovarian, breast, or endometrial cancer
Known BRCA1 or BRCA2 gene mutation carriers
Your Comfortable Visit
A simple, step-by-step CA-125 scan process designed for comfort, speed, and accuracy.
Test Pricing
CA-125 pricing in Dubai varies by service type and insurance coverage for various test types.
- Pricing varies by scan type and whether contrast is required
- Insurance coverage accepted with referral and verification
- Transparent self-pay rates available with instant quote on request
Insurance verification in minutes • No hidden fees • Fast response on WhatsApp
Patient Guide
Your Lab Test Experience
Quick, comfortable, and straightforward.
Insurance & Location
Insurance Partners
- •20+ insurance providers in Dubai including Daman, AXA, ADNIC, and others
- •Pre-authorization support and direct billing (where applicable)
- •Coverage verification before your appointment at our Dubai Healthcare City clinic
- •Transparent pricing with no hidden fees for ca-125 test services
Visit Us in Dubai Healthcare City
Doctors Clinic Diagnostic Center
Building 64, Block A, Al Razi Medical Complex, Dubai Healthcare City, Dubai, UAE
Near Oud Metha Road · Easy access from Bur Dubai, Downtown Dubai, Business Bay · Free dedicated parking available
Working Hours
Mon-Thu, Sat: 8AM - 10:30PM | Sun: 8:30AM - 10:30PM | Fri: 9AM - 10PM
How Insurance Works at DCDC
Check Coverage
Verify your plan covers CA-125 Test
Get a Referral
Some insurers require a GP referral — we can guide you
Pre-Authorization
We handle pre-auth directly with your insurer
Direct Billing
No upfront payment — we bill your insurer directly
Co-Pay Only
You only pay any applicable co-pay at the clinic
Check Coverage
Verify your plan covers CA-125 Test
Get a Referral
Some insurers require a GP referral — we can guide you
Pre-Authorization
We handle pre-auth directly with your insurer
Direct Billing
No upfront payment — we bill your insurer directly
Co-Pay Only
You only pay any applicable co-pay at the clinic
Your Specialist
Dr. Hadi Komshi
Specialist Internal Medicine
MD, Specialist Internal Medicine
Persian · Arabic · English
Conditions and Cancers Assessed Through CA-125 Testing
Epithelial Ovarian Cancer
The most common type of ovarian cancer, with CA-125 elevated in approximately 80 percent of advanced cases and 50 percent of early-stage disease.
Fallopian Tube Cancer
Primary fallopian tube carcinoma, now recognised as closely related to high-grade serous ovarian cancer, with similar CA-125 elevation patterns.
Primary Peritoneal Cancer
Peritoneal carcinomatosis arising from peritoneal surfaces, sharing histology and CA-125 marker behaviour with epithelial ovarian cancer.
Endometriosis
Chronic pelvic condition frequently causing CA-125 elevation proportional to disease severity, useful for monitoring treatment response.
Related Services
Explore other diagnostic and consultation services available at our Dubai Healthcare City clinic.
Frequently Asked Questions
Common questions about CA-125 Test in Dubai.
CA-125 is a glycoprotein normally expressed on cells lining the ovaries, fallopian tubes, endometrium, and peritoneum. Ovarian cancer cells produce significantly increased quantities, causing blood levels to rise above the normal threshold of 35 U/mL.
Yes, very commonly. In premenopausal women, 90 percent of CA-125 elevations are benign.
No. Major guidelines do not recommend CA-125 for general population screening due to limited sensitivity for early-stage cancer and high false-positive rates in premenopausal women.
During chemotherapy, declining CA-125 correlates with tumour response; normalization below 35 U/mL is associated with improved survival. CA-125 half-life below 14 days predicts better outcomes.
CA-125 is frequently elevated in endometriosis, correlating with disease severity. Mild disease may cause modest increases to 35-50 U/mL; severe disease with endometriomas can exceed 100-200 U/mL.
Key Facts
Medical Review & Oversight
All services are provided under the supervision of licensed medical professionals in our MOHAP-accredited facility.